Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference (Q37191449)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2009

Language	Label	Description	Also known as
English	Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference	scientific article published on May 2009

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference (English)

1 reference

Europe PubMed Central

18 August 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

David T Felson

3

0 references

4

object named as

George Wells

1 reference

Europe PubMed Central

18 August 2017

author name string

Lilian H D van Tuyl

1

1 reference

Europe PubMed Central

18 August 2017

Steven C Vlad

2

1 reference

Europe PubMed Central

18 August 2017

Maarten Boers

5

1 reference

Europe PubMed Central

18 August 2017

publication date

1 May 2009

1 reference

Europe PubMed Central

18 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

18 August 2017

61

1 reference

Europe PubMed Central

18 August 2017

5

1 reference

Europe PubMed Central

18 August 2017

704-710

1 reference

Europe PubMed Central

18 August 2017

Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

Remission by composite scores in rheumatoid arthritis: are ankles and feet important?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

Minimal disease activity for rheumatoid arthritis: a preliminary definition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

MCID/Low Disease Activity State Workshop: low disease activity state in rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

6 September 2017

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

14 September 2017

Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

26 June 2018

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

26 June 2018

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

3 September 2018

Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

3 September 2018

Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

3 September 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681785

3 September 2018

Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary criteria for clinical remission in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing remission in clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The problem of rheumatoid arthritis disease activity and remission in clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The OMERACT filter for Outcome Measures in Rheumatology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19405006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ART.24392

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37191449&oldid=2120379590"